About Molecular Devices
Molecular Devices is a company based in Sunnyvale (United States) founded in 1983 was acquired by Danaher in September 2009.. Molecular Devices has completed 2 acquisitions, including Cellesce and LJL BioSystems. Molecular Devices offers products and services including SpectraMax Microplate Readers, SoftMax Pro Software, and CellXpress.ai Automated Cell Culture System. Molecular Devices operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecular Devices
Molecular Devices offers a comprehensive portfolio of products and services, including SpectraMax Microplate Readers, SoftMax Pro Software, and CellXpress.ai Automated Cell Culture System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Devices for high-throughput screening in life science assays.
Software for processing data from microplate readers.
Automated system for reliable cell culture and imaging workflows.
Unlock access to complete
Funding Insights of Molecular Devices
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molecular Devices
Molecular Devices has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Danaher and mdsinc.com. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Dental equipment and medical instruments are manufactured for therapeutic areas.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molecular Devices
Molecular Devices has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cellesce and LJL BioSystems. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Scalable processes for organoid expansion are developed.
|
2013 | ||||
|
Fluorescence detection instruments for life sciences are developed.
|
1988 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Molecular Devices
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molecular Devices Comparisons
Competitors of Molecular Devices
Molecular Devices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| domain | founded_year | HQ Location |
Online platform offering life sciences reagents and kits
|
|
| domain | founded_year | HQ Location |
Portfolio of products and services for life science research and clinical diagnostic markets
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Molecular Devices
Frequently Asked Questions about Molecular Devices
When was Molecular Devices founded?
Molecular Devices was founded in 1983.
Where is Molecular Devices located?
Molecular Devices is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
What does Molecular Devices do?
Founded in 1983 and based in Sunnyvale, United States, automated solutions for life science research are offered by the company. These encompass cell culture systems, high-content imaging platforms, microplate readers, and clone screening tools. Operations focus on high-throughput screening, plate-based assays, and organoid production services, with GxP compliance support for GMPGLP laboratories. Drug discovery and cell line development are facilitated across research workflows.
Who are the top competitors of Molecular Devices?
Molecular Devices's top competitors include Biocare Medical, Merck and Siemens Healthineers.
What products or services does Molecular Devices offer?
Molecular Devices offers SpectraMax Microplate Readers, SoftMax Pro Software, and CellXpress.ai Automated Cell Culture System.
How many acquisitions has Molecular Devices made?
Molecular Devices has made 2 acquisitions, including Cellesce, and LJL BioSystems.
Who are Molecular Devices's investors?
Molecular Devices has 2 investors. Key investors include Danaher, and mdsinc.com.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.